Oct 1, 2026 07:34AM
Oct 1, 2026 07:30AM
Sep 30, 2026 10:31AM
Sep 30, 2026 10:30AM
Sep 28, 2026 08:02AM
Sep 28, 2026 08:00AM
Aug 25, 2026 08:30AM Nektar's atopic dermatitis drug data published in The Lancet
Aug 25, 2026 08:30AM
Jul 21, 2026 07:00AM
Jul 21, 2026 07:00AM
May 7, 2026 04:15PM
Apr 20, 2026 10:21AM
Apr 20, 2026 07:43AM
Apr 20, 2026 07:30AM 52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin
Mar 28, 2026 12:36PM
Mar 28, 2026 12:36PM
Mar 20, 2026 10:00AM
Mar 20, 2026 10:00AM
Mar 10, 2026 09:08AM
Feb 19, 2026 05:31PM
Feb 17, 2026 07:00AM Nektar Therapeutics Announces Research Collaboration with UCSF and Dr. Stephen Hauser for NKTR-0165, a Tumor Necrosis Factor Receptor 2 (TNFR2) Antibody, in Multiple Sclerosis
Feb 16, 2026 05:31PM
Feb 10, 2026 07:01AM
Feb 10, 2026 07:00AM
Dec 16, 2025 07:30AM
Dec 16, 2025 07:30AM
Nov 8, 2025 05:45PM
Nov 6, 2025 04:15PM Nektar Therapeutics Reports Third Quarter 2025 Financial Results
Oct 22, 2025 08:00AM
Sep 18, 2025 08:46AM
Sep 18, 2025 08:45AM
Sep 9, 2025 07:00AM
Aug 7, 2025 04:15PM
Jul 29, 2025 09:01AM
Jul 29, 2025 09:00AM Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
Jun 24, 2025 07:31AM
Jun 24, 2025 07:30AM
May 8, 2025 04:15PM
Mar 12, 2025 04:15PM
Feb 26, 2025 07:01AM
Feb 26, 2025 07:00AM
Feb 24, 2025 07:00AM Nektar Therapeutics (NKTR) Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus
Feb 24, 2025 07:00AM
Feb 24, 2025 07:00AM
Feb 10, 2025 07:01AM
Feb 10, 2025 07:00AM
Dec 7, 2024 12:00PM
Nov 4, 2024 08:30AM
Nov 4, 2024 08:30AM Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in Alabama
Mar 19, 2024 04:15PM

333,197 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All